UCHL5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.890400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.794800E-01
Normal-vs-Stage2
7.189000E-01
Normal-vs-Stage3
2.161400E-01
Normal-vs-Stage4
3.420200E-01
Stage1-vs-Stage2
7.979200E-01
Stage1-vs-Stage3
2.342200E-01
Stage1-vs-Stage4
4.398600E-01
Stage2-vs-Stage3
1.639190E-01
Stage2-vs-Stage4
1.122020E-01
Stage3-vs-Stage4
1.170210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.273200E-01
Normal-vs-AfricanAmerican
2.993800E-02
Normal-vs-Asian
7.991400E-01
Caucasian-vs-AfricanAmerican
6.360900E-03
Caucasian-vs-Asian
7.853600E-01
AfricanAmerican-vs-Asian
1.920370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.257400E-01
Normal-vs-Female
7.296000E-01
Male-vs-Female
6.315000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.233400E-01
Normal-vs-Age(41-60Yrs)
6.021400E-01
Normal-vs-Age(61-80Yrs)
8.711800E-01
Normal-vs-Age(81-100Yrs)
6.712200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.039550E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.706040E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.255250E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.699650E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.127600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.122400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.099000E-01
Normal-vs-Daily Drinker
6.035800E-01
Normal-vs-Weekly Drinker
9.778800E-01
Normal-vs-Occasional Drinker
5.237000E-01
Normal-vs-Social Drinker
7.657600E-01
Non Drinker-vs-Daily Drinker
6.799600E-02
Non Drinker-vs-Weekly Drinker
5.221800E-01
Non Drinker-vs-Occasional Drinker
6.227200E-01
Non Drinker-vs-Social Drinker
9.987000E-01
Daily Drinker-vs-Weekly Drinker
3.431600E-01
Daily Drinker-vs-Occasional Drinker
3.286200E-02
Daily Drinker-vs-Social Drinker
1.565810E-01
Weekly Drinker-vs-Occasional Drinker
3.028000E-01
Weekly Drinker-vs-Social Drinker
6.172600E-01
Occasional Drinker-vs-Social Drinker
7.008800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.246400E-01
Normal-vs-Grade 2
5.461600E-02
Normal-vs-Grade 3
6.670100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.085800E-02
Grade 1-vs-Grade 3
6.155700E-03
Grade 1-vs-Grade 4
2.246400E-01
Grade 2-vs-Grade 3
1.088790E-01
Grade 2-vs-Grade 4
5.461600E-02
Grade 3-vs-Grade 4
6.670100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.917200E-01
Normal-vs-NonDiabetic
8.551400E-01
Diabetic-vs-NonDiabetic
5.541600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.574200E-01
Normal-vs-NoPancreatitis
8.623800E-01
Pancreatitis-vs-NoPancreatitis
8.126200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.618600E-01
Normal-vs-N1
7.535200E-01
N0-vs-N1
8.814600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.043200E-01
Normal-vs-TP53-NonMutant
7.845000E-01
TP53-Mutant-vs-TP53-NonMutant
3.863400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
